Copyright Reports & Markets. All rights reserved.

Global Hyperkalemia Treatment Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hyperkalemia Treatment Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Patiromer
    • 1.3.3 Sodium Zirconium Cyclosilicate
  • 1.4 Market Analysis by Distribution Channel
    • 1.4.1 Overview: Global Hyperkalemia Treatment Consumption Value by Distribution Channel: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital Pharmacy
    • 1.4.3 Retail Pharmacy
  • 1.5 Global Hyperkalemia Treatment Market Size & Forecast
    • 1.5.1 Global Hyperkalemia Treatment Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Hyperkalemia Treatment Sales Quantity (2019-2030)
    • 1.5.3 Global Hyperkalemia Treatment Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Vifor Pharma
    • 2.1.1 Vifor Pharma Details
    • 2.1.2 Vifor Pharma Major Business
    • 2.1.3 Vifor Pharma Hyperkalemia Treatment Product and Services
    • 2.1.4 Vifor Pharma Hyperkalemia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Vifor Pharma Recent Developments/Updates
  • 2.2 Astrazeneca
    • 2.2.1 Astrazeneca Details
    • 2.2.2 Astrazeneca Major Business
    • 2.2.3 Astrazeneca Hyperkalemia Treatment Product and Services
    • 2.2.4 Astrazeneca Hyperkalemia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Astrazeneca Recent Developments/Updates
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi Hyperkalemia Treatment Product and Services
    • 2.3.4 Sanofi Hyperkalemia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Sanofi Recent Developments/Updates
  • 2.4 CMP Pharma
    • 2.4.1 CMP Pharma Details
    • 2.4.2 CMP Pharma Major Business
    • 2.4.3 CMP Pharma Hyperkalemia Treatment Product and Services
    • 2.4.4 CMP Pharma Hyperkalemia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 CMP Pharma Recent Developments/Updates
  • 2.5 Belcher Pharmaceuticals
    • 2.5.1 Belcher Pharmaceuticals Details
    • 2.5.2 Belcher Pharmaceuticals Major Business
    • 2.5.3 Belcher Pharmaceuticals Hyperkalemia Treatment Product and Services
    • 2.5.4 Belcher Pharmaceuticals Hyperkalemia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Belcher Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Hyperkalemia Treatment by Manufacturer

  • 3.1 Global Hyperkalemia Treatment Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Hyperkalemia Treatment Revenue by Manufacturer (2019-2024)
  • 3.3 Global Hyperkalemia Treatment Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Hyperkalemia Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Hyperkalemia Treatment Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Hyperkalemia Treatment Manufacturer Market Share in 2023
  • 3.5 Hyperkalemia Treatment Market: Overall Company Footprint Analysis
    • 3.5.1 Hyperkalemia Treatment Market: Region Footprint
    • 3.5.2 Hyperkalemia Treatment Market: Company Product Type Footprint
    • 3.5.3 Hyperkalemia Treatment Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hyperkalemia Treatment Market Size by Region
    • 4.1.1 Global Hyperkalemia Treatment Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Hyperkalemia Treatment Consumption Value by Region (2019-2030)
    • 4.1.3 Global Hyperkalemia Treatment Average Price by Region (2019-2030)
  • 4.2 North America Hyperkalemia Treatment Consumption Value (2019-2030)
  • 4.3 Europe Hyperkalemia Treatment Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Hyperkalemia Treatment Consumption Value (2019-2030)
  • 4.5 South America Hyperkalemia Treatment Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Hyperkalemia Treatment Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Hyperkalemia Treatment Sales Quantity by Type (2019-2030)
  • 5.2 Global Hyperkalemia Treatment Consumption Value by Type (2019-2030)
  • 5.3 Global Hyperkalemia Treatment Average Price by Type (2019-2030)

6 Market Segment by Distribution Channel

  • 6.1 Global Hyperkalemia Treatment Sales Quantity by Distribution Channel (2019-2030)
  • 6.2 Global Hyperkalemia Treatment Consumption Value by Distribution Channel (2019-2030)
  • 6.3 Global Hyperkalemia Treatment Average Price by Distribution Channel (2019-2030)

7 North America

  • 7.1 North America Hyperkalemia Treatment Sales Quantity by Type (2019-2030)
  • 7.2 North America Hyperkalemia Treatment Sales Quantity by Distribution Channel (2019-2030)
  • 7.3 North America Hyperkalemia Treatment Market Size by Country
    • 7.3.1 North America Hyperkalemia Treatment Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Hyperkalemia Treatment Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Hyperkalemia Treatment Sales Quantity by Type (2019-2030)
  • 8.2 Europe Hyperkalemia Treatment Sales Quantity by Distribution Channel (2019-2030)
  • 8.3 Europe Hyperkalemia Treatment Market Size by Country
    • 8.3.1 Europe Hyperkalemia Treatment Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Hyperkalemia Treatment Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hyperkalemia Treatment Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Hyperkalemia Treatment Sales Quantity by Distribution Channel (2019-2030)
  • 9.3 Asia-Pacific Hyperkalemia Treatment Market Size by Region
    • 9.3.1 Asia-Pacific Hyperkalemia Treatment Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Hyperkalemia Treatment Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Hyperkalemia Treatment Sales Quantity by Type (2019-2030)
  • 10.2 South America Hyperkalemia Treatment Sales Quantity by Distribution Channel (2019-2030)
  • 10.3 South America Hyperkalemia Treatment Market Size by Country
    • 10.3.1 South America Hyperkalemia Treatment Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Hyperkalemia Treatment Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hyperkalemia Treatment Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Hyperkalemia Treatment Sales Quantity by Distribution Channel (2019-2030)
  • 11.3 Middle East & Africa Hyperkalemia Treatment Market Size by Country
    • 11.3.1 Middle East & Africa Hyperkalemia Treatment Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Hyperkalemia Treatment Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Hyperkalemia Treatment Market Drivers
  • 12.2 Hyperkalemia Treatment Market Restraints
  • 12.3 Hyperkalemia Treatment Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hyperkalemia Treatment and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hyperkalemia Treatment
  • 13.3 Hyperkalemia Treatment Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hyperkalemia Treatment Typical Distributors
  • 14.3 Hyperkalemia Treatment Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Hyperkalemia is a diseases in which levels of potassium are higher than normal level (3.5 and 5.0 mmol/L) in blood serum. Kidneys are responsible for managing potassium balance in the body by regulating its excretion as well as its intake. A person is prone to develop hyperkalemia when the consumption of potassium exceeds that of kidneys’ potential to excrete it. The right amount of potassium and sodium in the body play a vital role in normal functioning of the myocardium.

    Hyperkalemia can occur due to congestive heart failure, chronic kidney disease, or diabetic kidney disease. The condition can also occur when a patient receives renin-angiotensin-aldosterone system inhibitors (RAAS) in kidney disease. Abnormal levels of potassium can lead to irregular heartbeats, which can be fatal. Hyperkalemia is diagnosed by kidney functioning test, creatinine blood test, blood tests, and glucose monitoring.
    According to our (Global Info Research) latest study, the global Hyperkalemia Treatment market size was valued at US$ 682 million in 2023 and is forecast to a readjusted size of USD 2468 million by 2030 with a CAGR of 20.4% during review period.
    The main manufacturers of Global Hyperkalemia Treatment include Vifor Pharma, Astrazeneca, etc. These top two manufacturers hold a market share about 50%. North America and Europe are the major producing regions in the world.
    This report is a detailed and comprehensive analysis for global Hyperkalemia Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Hyperkalemia Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
    Global Hyperkalemia Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
    Global Hyperkalemia Treatment market size and forecasts, by Type and by Distribution Channel, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
    Global Hyperkalemia Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hyperkalemia Treatment
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hyperkalemia Treatment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vifor Pharma, Astrazeneca, Sanofi, CMP Pharma, Belcher Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Hyperkalemia Treatment market is split by Type and by Distribution Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Patiromer
    Sodium Zirconium Cyclosilicate
    Market segment by Distribution Channel
    Hospital Pharmacy
    Retail Pharmacy
    Major players covered
    Vifor Pharma
    Astrazeneca
    Sanofi
    CMP Pharma
    Belcher Pharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hyperkalemia Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hyperkalemia Treatment, with price, sales quantity, revenue, and global market share of Hyperkalemia Treatment from 2019 to 2024.
    Chapter 3, the Hyperkalemia Treatment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hyperkalemia Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Distribution Channel, with sales market share and growth rate by Type, by Distribution Channel, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Hyperkalemia Treatment market forecast, by regions, by Type, and by Distribution Channel, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hyperkalemia Treatment.
    Chapter 14 and 15, to describe Hyperkalemia Treatment sales channel, distributors, customers, research findings and conclusion.

    Buy now